Emerging antiviral defense systems are expanding the conceptual and practical boundaries of genome editing. Across bacteria, archaea, and eukaryotes, hosts ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented ...

R3 Bio has a bold idea for replacing lab animals: genetically-engineered whole organ systems that lack a brain. The long-term ...

CRISPR recently raised nearly $600 million through a private offering, which weighed down its share price. The company has an ...

Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live ...

Researchers used the world’s brightest X-rays to image intact organs in unprecedented detail and created an open access ...

AI and multimodal data are driving a shift toward N-of-1 medicine, tailoring interventions to a person's unique biological ...

Cancer is often thought of as a single disease. Yet even tumors that arise in the same organ can follow very different ...

A newly identified cellular system monitors subtle variations in genetic coding, hinting at a hidden level of control over ...

A genetic variant carried by at least one-fifth of the population may do far more than raise the odds of developing Alzheimer ...

Researchers at UC San Francisco have now developed a way to reprogram these cancer-fighting cells directly inside the body. This new method could remove the need for external manufacturing, ...

With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...